These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 3877862

  • 1. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P.
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Nov; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 4. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonucci E, Taggi F.
    Miner Electrolyte Metab; 1989 Nov; 15(5):295-302. PubMed ID: 2811788
    [Abstract] [Full Text] [Related]

  • 5. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Nov; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 6. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L.
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [Abstract] [Full Text] [Related]

  • 7. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J, Velasco N, Catto GR, Fraser RA, Edward N, Adami S, O'Riordan JL.
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [Abstract] [Full Text] [Related]

  • 8. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K, Reinhardt D, Grosse-Hohmann E, Keck E.
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [Abstract] [Full Text] [Related]

  • 9. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
    Massry SG, Tuma S, Dua S, Goldstein DA.
    J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D metabolism in women with femoral neck fracture.
    Hordon LD, Peacock M.
    Bone Miner; 1987 Aug; 2(5):413-26. PubMed ID: 2851340
    [Abstract] [Full Text] [Related]

  • 11. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL, Felsenfeld AJ, Llach F.
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [Abstract] [Full Text] [Related]

  • 12. Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats.
    Vukicević S, Krempien B, Stavljenić A.
    J Bone Miner Res; 1987 Dec; 2(6):533-45. PubMed ID: 3502683
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

  • 14. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G, Mazzaferro S, Bonucci E, Ballanti P, Massimetti C, Donato G, Landi A, Smacchi A, Della Rocca C, Cinotti GA.
    Miner Electrolyte Metab; 1986 Feb; 12(5-6):375-82. PubMed ID: 3492662
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of secondary hyperparathyroidism with vitamin D metabolites].
    Stojimirović B, Pejanović S, Djukanović Lj.
    Srp Arh Celok Lek; 1994 Feb; 122(7-8):197-9. PubMed ID: 17974384
    [Abstract] [Full Text] [Related]

  • 16. Plasma 1,25(OH)2D3 and iPTH in transplanted adults with persisting hypophosphataemia.
    Ulmann A, Chkoff N, Garabedian M, Lacour B, Descamps JM, Kreis H, Crosnier J, Funck-Brentano JL.
    Proc Eur Dial Transplant Assoc; 1980 Feb; 17():467-72. PubMed ID: 7017692
    [Abstract] [Full Text] [Related]

  • 17. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW.
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [Abstract] [Full Text] [Related]

  • 18. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD.
    Miner Electrolyte Metab; 1995 Jun; 21(6):398-402. PubMed ID: 8592483
    [Abstract] [Full Text] [Related]

  • 19. [Effect of 24,25-dioxycholecalciferol on calcium-phosphorus metabolism and bone tissue in rats with experimental renal failure].
    Alekseeva IA.
    Vopr Pitan; 1984 Jun; (3):55-8. PubMed ID: 6332422
    [Abstract] [Full Text] [Related]

  • 20. Treatment with vitamin 24,25 (OH)2D3 does not change serum levels of 1,25 (OH)2D or urinary calcium excretion rate in man.
    Thomsen K, Riis BJ, Hummer L, Christiansen C.
    Acta Vitaminol Enzymol; 1985 Jun; 7(3-4):167-71. PubMed ID: 3879105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.